Regulatory Science Framework for assessment of risk benefit ratio of Nanomedicines and Biomaterials
31 May 2017
ERA-NET Cofund on Biotechnologies
31 May 2017
Show all

Development of a reliable methodology for better risk management of engineered biomaterials in Advanced Therapy Medicinal Products and/or Medical Devices

This content is restricted to site members. If you are an existing user, please log in.

Existing Users Log In